Please try another search
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. Its lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion due to fluid overload in adults with chronic heart failure and kidney disease, as well as consists of subcutaneous loop diuretic that delivers IV equivalent diuresis at home; and FUROSCIX On-Body Infusor, a drug-device combination product consisting of FUROSCIX. The company’s product pipeline also includes SCP-111 (furosemide injection), an investigational pH neutral aqueous furosemide formulation that is being developed for subcutaneous administration outside of the hospital setting, including patient self-administration in the home; and SCP-111 Autoinjector, an investigational single-entity, drug-device combination product candidate consisting of a prefilled syringe containing SCP-111, preloaded into a commercially available, fixed single dose, disposable, two step mechanical autoinjector. It has a collaboration agreement with West Pharmaceutical Services, Inc. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Jack A. Khattar | 63 | 2016 | Independent Chairman of the Board |
Klaus R. Veitinger | 62 | 2017 | Independent Director |
Dan Bensimhon | - | - | Member of Scientific Advisory Board |
William S. Weintraub | - | - | Member of Scientific Advisory Board |
William T. Abraham | 64 | 2021 | Independent Director |
Mette Kirstine Agger | 60 | 2014 | Independent Director |
Leonard D. Schaeffer | 78 | 2014 | Independent Director |
Marvin A. Konstam | - | - | Member of Scientific Advisory Board |
Frederick M. Hudson | 79 | 2018 | Independent Director |
John H. Tucker | 61 | 2016 | President, CEO, Principal Executive Officer & Director |
Sara M. Bonstein | 43 | 2020 | Independent Director |
Minnie V. Baylor-Henry | 76 | 2018 | Independent Director |
Stuart Russell | - | - | Member of Scientific Advisory Board |
G. Michael Felker | - | - | Member of Scientific Advisory Board |
William Franklin Peacock | - | - | Member of Scientific Advisory Board |
James E. Udelson | - | - | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review